Companies / ASTH Astrana Health, Inc. (ASTH)
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
Ticker ASTH Exchange Nasdaq Sector Healthcare Industry Medical Care Facilities Market cap $1.70B 52-week range $18.08 - $51.60 Valuation Share price $34.50 (close of Nov 6, 2026) P/E (TTM) 31.94x Price to book 1.96x Price to free cash flow 17.08x Enterprise value $2.28B Book value per share $17.64 Price performance Period Change 1 day -11.56% 5 days -5.56% 1 month -6.76% 3 months +1.08% 6 months -2.13% Year to date +39.06% 1 year +3.42% 3 years +17.59% 5 years -59.88% 10 years +666.67% All time +267.02%
Short interest As of Oct 15, 2026 Short % of float 11.56% Shares short 3.01M Days to cover 8.85 Change since prior report -2.49% Source FINRA consolidated short interest Profitability and growth Return on equity 2.83% Return on invested capital 3.37% Return on assets 1.01% Return on capital employed 4.90% Gross margin 9.30% Net margin 0.71% EBITDA margin 3.91% Revenue growth 56.39% Net income growth -47.89% Free cash flow growth 136.58% Cash flow and balance sheet Free cash flow yield (TTM) 5.85% Current ratio 1.25x Net debt to EBITDA 2.81x Latest reported year Period end Dec 31, 2025 Fiscal year 2025 Revenue $3.18B Cost of revenue $2.89B Gross profit $295.78M EBITDA $124.27M Net income $22.49M Earnings per share $0.46 Interest expense $49.93M Shares outstanding 49.08M Income statement by year Period end Revenue Gross profit Net income EPS 2025-12-31 $3.18B $295.78M $22.49M $0.46 2024-12-31 $2.03B $243.46M $43.15M $0.91 2023-12-31 $1.39B $197.21M $60.72M $1.30 2022-12-31 $1.14B $181.94M $45.17M $1.00 2021-12-31 $773.91M $177.77M $68.92M $1.57 2020-12-31 $687.18M $147.97M $37.69M $1.03 2019-12-31 $560.62M $92.81M $14.12M $0.41 2018-12-31 $519.91M $158.78M $10.84M $0.33 2017-12-31 $356.36M $82.90M $25.80M $1.01 2017-03-31 $57.43M $8.69M -$8.97M -$1.49
Margins and returns by year Period end Gross margin Net margin Return on equity Return on capital 2025-12-31 9.30% 0.71% 2.83% 3.37% 2024-12-31 11.97% 2.12% 6.02% 4.92% 2023-12-31 14.22% 4.38% 9.85% 5.61% 2022-12-31 15.90% 3.95% 8.30% 8.19% 2021-12-31 22.97% 8.91% 15.18% 10.15% 2020-12-31 21.53% 5.48% 11.44% 6.82% 2019-12-31 16.56% 2.52% 7.34% 5.40% 2018-12-31 30.54% 2.08% 5.97% 33.79% 2017-12-31 23.26% 7.24% 15.72% 19.04% 2017-03-31 15.14% -15.62% - -103.14%
Cash and debt by year Period end Cash Debt 2025-12-31 $429.47M $990.90M 2024-12-31 $288.45M $425.30M 2023-12-31 $293.81M $258.94M 2022-12-31 $288.03M $203.39M 2021-12-31 $233.10M $182.92M 2020-12-31 $193.47M $230.21M 2019-12-31 $103.19M $232.17M 2018-12-31 $106.89M $5.00M 2017-12-31 $99.75M - 2017-03-31 $8.66M -
Free cash flow by year Period end Free cash flow Stock-based compensation 2025-12-31 $104.49M $38.60M 2024-12-31 $44.17M $34.54M 2023-12-31 $39.70M $22.04M 2022-12-31 $59.19M $16.10M 2021-12-31 $51.11M $6.75M 2020-12-31 $45.00M $3.38M 2019-12-31 $12.63M $1.55M 2018-12-31 $24.33M $1.44M 2017-12-31 $49.75M $2.74M 2017-03-31 -$8.44M $1.11M
Investor relations Past earnings dates Reported Fiscal period EPS estimate 2026-11-05 Sep 2026 $0.44 2026-08-06 Jun 2026 $0.31 2026-05-07 Mar 2026 $0.29 2026-03-02 Dec 2025 $0.15 2025-11-06 Sep 2025 $0.47 2025-08-07 Jun 2025 $0.36 2025-05-08 Mar 2025 $0.23 2025-02-27 Dec 2024 $0.09
Filings and sources Company website astranahealth.com SEC filings 10-K, 10-Q and 8-K on EDGAR Earnings calendar All upcoming reports Similar companies HCA Healthcare, Inc. (HCA) · DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR) · Natera, Inc. (NTRA) · Agilent Technologies, Inc. (A) · IQVIA Holdings Inc. (IQV)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades